LYS MEDICAL
De berekende faillissementskans van LYS MEDICAL over 12 maanden bedraagt 0,4% (zeer laag). Het bedrijf is actief sinds 2018 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 8 jaar |
| Bestuur | 1 |
| Vestigingen | 1 |
| Publicaties | 14 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | micro | 01-08-2025 | 2025-00360619 |
| 31-12-2023 | micro | 26-08-2024 | 2024-00378457 |
| 31-12-2022 | micro | 09-08-2023 | 2023-00324457 |
| 31-12-2021 | micro | 17-08-2022 | 2022-20298841 |
| 31-12-2020 | micro | 09-07-2021 | 2021-34100595 |
| 31-12-2019 | micro | 10-09-2020 | 2020-52400462 |
| 31-12-2018 | micro | 27-06-2019 | 2019-26300529 |
-
Actief01-03-2024 → heden
Historisch, niet recent bevestigd (4)
-
Niet recent bevestigdlaatst bevestigd in akte van 2020
-
Niet recent bevestigdlaatst bevestigd in akte van 2019
3 gebeurtenissen
- 04-11-2019 Ontslagen· Zaakvoerder
- 04-11-2019 Benoemd· Bestuurder
- 04-11-2019 Benoemd· Gedelegeerd bestuurder
-
CANARechtspersoonBestuurder· vast vert.: Jacques REYMANNStaatsblad-akte 19341834 (04-11-2019)Niet recent bevestigdlaatst bevestigd in akte van 2019
-
Niet recent bevestigdlaatst bevestigd in akte van 2019
Voormalige bestuurders (2)
-
FONDS DE CAPITAL A RISQUE 2020 SARechtspersoonBestuurder· vast vert.: Helena PoziosStaatsblad-akte 19341834 (04-11-2019)Voormalig04-11-2019 → 02-01-2023
2 gebeurtenissen
- 02-01-2023 Ontslagen· Bestuurder
- 04-11-2019 Benoemd· Bestuurder
-
Voormalig04-11-2019 → 25-02-2021
2 gebeurtenissen
- 25-02-2021 Ontslagen· Bestuurder
- 04-11-2019 Benoemd· Bestuurder
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| Deloitte Réviseur d'EntreprisesActief Commissaris · vertegenwoordigd door Julie Delforge |
- | 09-02-2023 → heden |
Toon 1 eerdere commissarissen
| Cabinet DELOITTE Commissaris · vertegenwoordigd door Julie DELFORGE opgevolgd door Deloitte Réviseur d'Entreprises in 2023 |
- | 11-03-2019 → 09-02-2023 |
| NACE primair | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 18-01-2018 |
| Status | Actief |
| Postcode | 6041 |
Toon 2 andere netwerkverbindingen
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 52028B0295/02C000 | Wallonië | 7.830 m² | - | - |
| 25110C0585/00D000 | Wallonië | 314 m² | 1 · 59 m² | - |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
Wij kennen 14 Staatsblad-aktes van dit bedrijf. Daarvan is er nog geen enkele gelezen: wat erin staat, is hier niet vastgesteld en ook niet weerlegd.
06-01-2026 Kapitaalverhoging van €1.000.000 tot €2.088.808,12
- €1.088.808,12 → €2.088.808,12
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1000000.0,
"currency": "EUR",
"after_eur": 2088808.12,
"delta_eur": 1000000.0,
"before_eur": 1088808.12,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-12-18",
"evidence_quote": "a d\u00E9cid\u00E9 de proc\u00E9der \u00E0 une augmentation de capital, par apport en num\u00E9raire au travers de la proc\u00E9dure du capital autoris\u00E9, \u00E0 concurrence d\u0027un montant de 1.000.000,00 \u20AC, pour le porter de 1.088.808,12 \u20AC \u00E0 2.088.808,12 \u20AC",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}19-06-2025 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-06-19",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}01-03-2024 Olivier Fructus benoemd tot bestuurder
- Olivier Fructus, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olivier Fructus",
"address": null,
"birth_date": null
},
"evidence_quote": "Le Conseil d\u00E9cide de coopter jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Ordinaire approuvant les comptes de l\u0027exercice 2023, Monsieur Olivier Fructus comme administrateur ind\u00E9pendant."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}20-11-2023 Kapitaalvermindering van €2.844.374,88 tot €1.084.643,12
- €3.929.018 → €1.084.643,12
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 712168.0,
"currency": "EUR",
"after_eur": 3929018.0,
"delta_eur": 712168.0,
"before_eur": 3216850.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-10-30",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital, \u00E0 concurrence de 712.168,00 \u20AC, pour le porter de 3.216.850,00 \u20AC \u00E0 3.929.018,00 \u20AC par apports en nature de cr\u00E9ances certaines et liquides d\u00E9tenues \u00E0 l\u0027\u00E9gard la Soci\u00E9t\u00E9",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 2844374.88,
"currency": "EUR",
"after_eur": 1084643.12,
"delta_eur": -2844374.88,
"before_eur": 3929018.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-10-30",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une r\u00E9duction de capital \u00E0 concurrence de 2.844.374,88 \u20AC, pour le ramener de 3.929.018,00 \u20AC \u00E0 1.084.643,12 \u20AC, sans annulation de titres, par pr\u00E9l\u00E8vement prioritaire \u00E0 due concurrence sur le capital fiscalement lib\u00E9r\u00E9 et par apurement des pertes report\u00E9es",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}09-02-2023 Julie Delforge herbenoemd als commissaris
- Julie Delforge, Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte Reviseur d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e, par vote sp\u00E9cial, d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de renouveler le mandat de Commissaire aux Comptes de la SCRL. Deloitte Reviseur d\u0027Entreprises, repr\u00E9sent\u00E9e par Julie Delforge pour les trois prochains exercices."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}02-01-2023 Kapitaalverhoging van €860.000 tot €3.216.850
- €2.356.850 → €3.216.850
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 703300.0,
"currency": "EUR",
"after_eur": 2356850.0,
"delta_eur": 703300.0,
"before_eur": 1653550.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-23",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital, \u00E0 concurrence de 703.300,00 \u20AC, pour le porter de 1.653.550,00 \u20AC \u00E0 2.356.850,00 \u20AC par apports en nature de cr\u00E9ances certaines et liquides d\u00E9tenues \u00E0 l\u0027\u00E9gard la Soci\u00E9t\u00E9",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 860000.0,
"currency": "EUR",
"after_eur": 3216850.0,
"delta_eur": 860000.0,
"before_eur": 2356850.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-23",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une seconde augmentation de capital par apports en num\u00E9raire, \u00E0 concurrence de 860.000,00 \u20AC, pour le porter de 2.356.850,00 \u20AC \u00E0 3.216.850,00 \u20AC",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}18-03-2022 Zetelverplaatsing binnen Gosselies
- Rue Auguste Piccard 37, 6041 Gosselies → Rue Auguste Piccard 48, 6041 Gosselies
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gosselies",
"region": null,
"street": "Rue Auguste Piccard",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "48"
},
"old_address": {
"city": "Gosselies",
"region": null,
"street": "Rue Auguste Piccard",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "37"
},
"effective_date": "2022-03-01",
"evidence_quote": "Il est approuv\u00E9 \u00E0 l\u0027unanimit\u00E9, l\u0027\u00E9tablissement du si\u00E8ge social au 48 rue Auguste Piccard \u00E0 6041 Gosselies, \u00E0 dater du 1/03/2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}25-02-2021 Jean Stephenne neemt ontslag als bestuurder
- Jean Stephenne, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean Stephenne",
"address": null,
"birth_date": null
},
"evidence_quote": "Par mail du 21 d\u00E9cembre 2020, Jean Stephenne qui pr\u00E9sidait le Conseil depuis 2019 a inform\u00E9 les Administrateurs de sa d\u00E9mission du Conseil et de la Pr\u00E9sidence. Le Conseil prend acte de cette d\u00E9mission"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}03-11-2020 Kapitaalverhoging van €575.000 tot €1.653.550
- €1.078.550 → €1.653.550
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 575000.0,
"currency": "EUR",
"after_eur": 1653550.0,
"delta_eur": 575000.0,
"before_eur": 1078550.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2020-10-08",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une augmentation de capital par apports en num\u00E9raire, \u00E0 concurrence de 575.000,00 \u20AC, pour le porter de 1.078.550,00 \u20AC \u00E0 1.653.550,00 \u20AC",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}04-09-2020 Zetelverplaatsing van Charleroi naar Gosselies
- Rue Auguste Piccard 48, 6041 Charleroi → Rue Auguste Piccard 37, 6041 Gosselies
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gosselies",
"region": null,
"street": "Rue Auguste Piccard",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "37"
},
"old_address": {
"city": "Charleroi",
"region": null,
"street": "Rue Auguste Piccard",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "48"
},
"effective_date": "2020-06-10",
"evidence_quote": "Le Conseil d\u00E9cide de d\u00E9placer le Si\u00E8ge Social du 48 au 37, rue Auguste Piccard \u00E0 6041 Gosselies"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}16-07-2020 Sylvain LANDAU benoemd tot bestuurder
- Sylvain LANDAU, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sylvain LANDAU",
"address": null,
"birth_date": null
},
"effective_date": "2020-07-03",
"evidence_quote": "L\u0027assembl\u00E9e nomme aux fonctions d\u0027administrateur, \u00E0 compter de ce jour pour une dur\u00E9e de 4 ans renouvelable: Monsieur Sylvain LANDAU, pr\u00E9cit\u00E9 (Wolf Sylvain LANDAU)"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SA"
}
}04-11-2019 Kapitaalverhoging van €790.350 tot €976.550
- €186.200 → €976.550
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 90912.5,
"currency": "EUR",
"after_eur": 186200.0,
"delta_eur": 90912.5,
"before_eur": 95287.5,
"amount_type": "kapitaal_effectief",
"effective_date": "2019-10-24",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une premi\u00E8re augmentation de capital par apports en num\u00E9raire, \u00E0 concurrence de 90.912,50 \u20AC, pour le porter de 95.287,50 \u20AC \u00E0 186.200,00 \u20AC",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 790350.0,
"currency": "EUR",
"after_eur": 976550.0,
"delta_eur": 790350.0,
"before_eur": 186200.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2019-10-24",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une deuxi\u00E8me augmentation de capital \u00E0 concurrence de 790.350,00 \u20AC pour le porter de 186.200,00 \u20AC \u00E0 976.550,00 \u20AC",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SPRL"
}
}11-03-2019 Kapitaalverhoging van €76.737,50 tot €95.287,50
- €18.550 → €95.287,50
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 76737.5,
"currency": "EUR",
"after_eur": 95287.5,
"delta_eur": 76737.5,
"before_eur": 18550.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2019-02-15",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital social, par apports en num\u00E9raire, \u00E0 concurrence de 76.737,50 \u20AC, pour le porter de 18.550,00 \u20AC \u00E0 95.287,50 \u20AC",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 361762.5,
"currency": "EUR",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"amount_type": "uitgiftepremie",
"effective_date": "2019-02-15",
"evidence_quote": "La diff\u00E9rence entre le montant de la souscription, soit 438.500,00 \u20AC, et la valeur de l\u0027augmentation de capital, soit 76.737,50 \u20AC, diff\u00E9rence s\u0027\u00E9levant donc \u00E0 361.762,50 \u20AC, sera affect\u00E9e \u00E0 un compte de prime d\u0027\u00E9mission.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SPRL"
}
}22-01-2018 Oprichting van een SNC
Technische details
{
"kind": "oprichting",
"seat": "6041 Gosselies, rue Auguste Piccard 48",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Monsieur MERTENS Benjamin Thomas",
"niss": null,
"address": "1332 Rixensart, Champ de la Garenne"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": "Monsieur MERTENS Benjamin Thomas",
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Monsieur DELCHAMBRE Alain Richard Jules Roger",
"niss": null,
"address": "1170 Watermael-Boitsfort"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": "Monsieur DELCHAMBRE Alain Richard Jules Roger",
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Monsieur DEVI\u00C8RE Jacques Maurice Edouard",
"niss": null,
"address": "1404 Nivelles, Chauss\u00E9e de Soignies 21"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": "Monsieur DEVI\u00C8RE Jacques Maurice Edouard",
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "La soci\u00E9t\u00E9 en commandite par actions \u00AB THEODORUS \u00BB"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "La soci\u00E9t\u00E9 en commandite par actions \u00AB THEODORUS \u00BB",
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 18550.0,
"subject_company": {
"kbo": "0688.626.061",
"name_full": "LYS MEDICAL",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2018-01-17",
"post_incorporation_mandates": []
}| Officiële naamFR | LYS MEDICAL |